Retatrutide is a newly developed drug that acts as a strong GLP-1 receptor agonist. This breakthrough approach holds significant potential for managing type 2 diabetes. By replicating the actions of natural GLP-1, Retatrutide improves insulin secretion and reduces glucagon release, leading to improved glycemic control. Clinical trials have demonstr